genprowebdirectory
Facebook Linkedin RSS Twitter Youtube
  • GEN Edge
    • Featured News
    • Multimedia
  • News
    • Insights
  • Topics
    • Artificial Intelligence
    • Bioprocessing
    • Cancer
    • Drug Discovery
    • Genome Editing
    • Infectious Diseases
    • OMICs
    • Translational Medicine
  • Magazine
    • Browse Issues
    • Subscribe
  • Multimedia
    • Summits
    • Webinars
    • GEN Live
    • Learning Labs
    • Podcasts
  • Resources
    • eBooks/Perspectives
    • Tutorials
    • Peer-Reviewed Journals
      • GEN Biotechnology
      • Re:Gen Open
    • New Products
    • Conference Calendar
  • Subscribe
    • Get GEN Magazine
    • Get GEN eNewsletters
Search
Facebook Linkedin RSS Twitter Youtube
Sign in
Welcome! Log into your account
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
A password will be e-mailed to you.
Genetic Engineering & Biotechnology News GEN – Genetic Engineering and Biotechnology News
Genetic Engineering & Biotechnology News Genetic Engineering & Biotechnology News
  • GEN Edge
    • Featured News
    • Multimedia
  • News
    • Insights
  • Topics
    • Artificial Intelligence
    • Bioprocessing
    • Cancer
    • Drug Discovery
    • Genome Editing
    • Infectious Diseases
    • OMICs
    • Translational Medicine
  • Magazine
    • Browse Issues
    • Subscribe
  • Multimedia
    • Summits
    • Webinars
    • GEN Live
    • Learning Labs
    • Podcasts
  • Resources
    • eBooks/Perspectives
    • Tutorials
    • Peer-Reviewed Journals
      • GEN Biotechnology
      • Re:Gen Open
    • New Products
    • Conference Calendar
  • Subscribe
    • Get GEN Magazine
    • Get GEN eNewsletters
Home 2023

Pacific Biosciences

StockWatch: Investors, Analysts Debate Background of New Illumina CEO
GEN Edge

StockWatch: Investors, Analysts Debate Background of New Illumina CEO

Alex Philippidis -
September 7, 2023
0
StockWatch: Despite 3-Week Decline, PacBio Stock Doubles in a Year
GEN Edge

StockWatch: Despite 3-Week Decline, PacBio Stock Doubles in a Year

Alex Philippidis -
August 30, 2023
0
Charms to Soothe the Savage Microbiome
Drug Discovery

Charms to Soothe the Savage Microbiome

Kathy Vuksanaj -
June 9, 2023
19
Illumina Shareholders Elect Ally of Icahn to Board, Ousting Chairman
News

Illumina Shareholders Elect Ally of Icahn to Board, Ousting Chairman

Alex Philippidis -
May 30, 2023
1
StockWatch: Icahn Pursues Illumina Board Seats, and a Sell-Off of Grail
News

StockWatch: Icahn Pursues Illumina Board Seats, and a Sell-Off of Grail

Alex Philippidis -
March 17, 2023
0
Legume’s Giant Genome Sequenced for First Time
News

Legume’s Giant Genome Sequenced for First Time

Julianna LeMieux, PhD -
March 14, 2023
0
Verkko Software Assembles T2T Genomes Without the Labwork
News

Verkko Software Assembles T2T Genomes Without the Labwork

Julianna LeMieux, PhD -
February 17, 2023
0
The Sun Sets on AGBT: A Report from the Last Day
Industry News

The Sun Sets on AGBT: A Report from the Last Day

Julianna LeMieux, PhD -
February 10, 2023
20
Spatial and NGS Dominate Proceedings at AGBT 2022
Insights

Spatial and NGS Dominate Proceedings at AGBT 2022

Julianna LeMieux, PhD -
February 6, 2023
1
The NGS Race Is On: Souped-Up Sequencers Vie for Frontrunner Status
Insights

The NGS Race Is On: Souped-Up Sequencers Vie for Frontrunner Status

Julianna LeMieux, PhD -
January 12, 2023
1
123Page 1 of 3

Read the Digital Edition

August 2023 cover

Explore

  • About GEN
  • Contact GEN
  • GEN Staff
  • Editorial Guidelines
  • Reprints and Permissions
  • Scientific Advisory Board

Advertise

  • Media Kit and Planning Calendar
  • Advertising Terms and Conditions

Resources

  • Get the GEN Magazine
  • Get the GEN Email Newsletter
  • Inside Precision Medicine
  • Privacy Policy
Copyright © 2023 Genetic Engineering & Biotechnology News. All Rights Reserved.
Scroll Up